StockData
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. (ENVB) stock

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.42+0.01 (+0.71%)

Close on Nov 18, 2026Market cap $6.36MP/E –Yield –

Enveric Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Enveric Biosciences's revenue for the twelve months ending Sep 30, 2020 was $35.41M, down 13.9% year over year. For fiscal 2019 it was $39.91M, down 7.2% from the year before. The highest annual figure on record is $48.59M in fiscal 2017.

Annual revenue

PeriodPeriod endValueChange
FY2019Dec 31, 2019$39.91M-7.2%
FY2018Dec 31, 2018$43.00M-11.5%
FY2017Dec 31, 2017$48.59M+34.4%
FY2016Dec 31, 2016$36.15M+78.4%
FY2015Dec 31, 2015$20.26M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020$8.48M-7.3%
Q2 FY2020Jun 30, 2020$8.25M-25.1%
Q1 FY2020Mar 31, 2020$9.60M-10.1%
Q4 FY2019Dec 31, 2019$9.06M-11.9%
Q3 FY2019Sep 30, 2019$9.15M-13.5%
Q2 FY2019Jun 30, 2019$11.02M-0.5%
Q1 FY2019Mar 31, 2019$10.69M-3.4%
Q4 FY2018Dec 31, 2018$10.28M-10.2%
Q3 FY2018Sep 30, 2018$10.58M-15.6%
Q2 FY2018Jun 30, 2018$11.08M-9.7%
Q1 FY2018Mar 31, 2018$11.06M-10.4%
Q4 FY2017Dec 31, 2017$11.45M-7.5%
Q3 FY2017Sep 30, 2017$12.53M+24.6%
Q2 FY2017Jun 30, 2017$12.27M–
Q1 FY2017Mar 31, 2017$12.34M–
Q4 FY2016Dec 31, 2016$12.39M–
Q3 FY2016Sep 30, 2016$10.06M–

More Enveric Biosciences figures

See a number that looks wrong?